Radiographic predictors of occult intracranial involvement in olfactory neuroblastoma patients

Author:

Geltzeiler Mathew1,Choby Garret W.23ORCID,Ji Keven Seung Yong1,JessMace C.1,Almeida Joao Paulo4,de Almeida John5,Champagne Pierre‐Olivier6,Chan Erik7,Ciporen Jeremy N.8,Chaskes Mark B.9,Cornell Sarah10,Drozdowski Veronica11,Fernandez‐Miranda Juan12,Gardner Paul A.13,Hwang Peter H.7,Kalyvas Aristotelis5,Kong Keonho A.9,McMillan Ryan A.2ORCID,Nayak Jayakar V.7ORCID,Patel Chirag11,Patel Zara M.7ORCID,Celda Maria Peris23,Pinheiro‐Neto Carlos23,Sanusi Olabisi R.8,Snyderman Carl H.14ORCID,Thorp Brian D.9,Van Gompel Jamie J.23,Zadeh Gelareh5,Zenonos Georgios13,Zwagerman Nathan T.10,Wang Eric W.14ORCID

Affiliation:

1. Department of Otolaryngology‐Head and Neck Surgery Oregon Health & Science University Portland Oregon USA

2. Department of Otolaryngology‐Head and Neck Surgery Mayo Clinic Rochester Minnesota USA

3. Department of Neurological Surgery Mayo Clinic Rochester Minnesota USA

4. Department of Neurological Surgery Mayo Clinic Jacksonville Florida USA

5. Department of Surgery University of Toronto Ontario Canada

6. Department of Neurological Surgery Universite Laval Quebec Canada

7. Department of Otolaryngology‐Head and Neck Surgery Stanford University Palo Alto California USA

8. Department of Neurological Surgery Oregon Health & Science University Portland Oregon USA

9. Department of Otolaryngology‐Head and Neck Surgery University of North Carolina Chapel Hill North Carolina USA

10. Department of Neurological Surgery Medical College of Wisconsin Milwaukee Wisconsin USA

11. Department of Otolaryngology‐Head and Neck Surgery Loyola University Medical Center Maywood Illinois USA

12. Department of Neurological Surgery Stanford University Palo Alto California USA

13. Department of Neurological Surgery University of Pittsburgh Medical Center Pittsburgh Pennsylvania USA

14. Department of Otolaryngology‐Head and Neck Surgery University of Pittsburgh Medical Center Pittsburgh Pennsylvania USA

Abstract

AbstractBackgroundTraditional management of olfactory neuroblastoma (ONB) includes margin‐negative resection with removal of cribriform plate, dura, and olfactory bulb, regardless of intracranial disease. This approach may be overtreating certain patients. Our investigation examines risk factors associated with occult intracranial disease to optimize therapeutic outcomes.MethodsThis retrospective, multi‐institutional cohort study examined clinical covariates associated with occult intracranial involvement. Patient demographics, staging, Hyam's grade, and pathologic involvement of dura, olfactory bulb/tract, and brain were collected. Diagnostic imaging was reviewed. Positive and negative predictive value (NPV) were estimated along with effect size estimates. Cox hazard regression examined associations with overall survival (OS) and disease‐free survival (DFS).ResultsA total of 224 subjects with new diagnoses of ONB (2005–2021) were identified. Skull base bone involvement on computed tomography (CT) had the highest NPV for pathologic dura (88.0%), olfactory bulb (88%), and brain involvement (97.3%). Hyam's grade category was significantly associated with dural involvement (φC = 0.26; 95% confidence interval [CI]: 0.16, 0.42). Subjects without radiologic skull base involvement (n = 66) had pathologic positivity of 12.1%. Within this subgroup, Hyam's grade was clinically significant for dural positivity (φ = 0.34; 95% CI: −0.12, 0.71) with 28.6% involvement in high grade tumors. Neither clinical nor pathologic positivity of intracranial structures were associated with significantly different OS or DFS.ConclusionsBoth CT and magnetic resonance imaging (MRI) had reasonably good NPV for involvement of dura and olfactory bulb. Higher Hyam's grade was associated with dural involvement. Patients with low‐grade tumors not involving the skull base may be suitable for avoiding skull base resection; however, further investigation is warranted.

Publisher

Wiley

Subject

Otorhinolaryngology,Immunology and Allergy

Reference41 articles.

1. A rare case report of mixed olfactory neuroblastoma: Carcinoma with review of literature

2. Olfactory neuroblastoma (esthesioneuroblastoma): towards minimally invasive surgery and multi‐modality treatment strategies – an updated critical review of the current literature;Papacharalampous GX;JBUON,2013

3. Chemotherapy for Esthesioneuroblastomas

4. Endoscopic versus open craniofacial resection of esthesioneuroblastoma: What is the evidence?

5. Esthesioneuroblastoma: Results and Outcomes of a Single Institution's Experience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3